In the November/December 2015 issue of PharmaVOICE, Rhett Johnson explains that to achieve better value, the health care industry must define what value looks like and measure how effectively it is being produced. To read the article, click here.
Asembia AXS25: Navigating the Evolving Landscape of GLP-1 Medications
Davis discussed the transition from obesity-specific opt-in benefits to more standard coverage. She expects that payers will need to handle a wider range of...